Cardiff Lexington Corp financial data

Symbol
CDIX on OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV
State of incorporation
FL
Fiscal year end
December 31
Former names
CARDIFF INTERNATIONAL INC (to 1/26/2018)
Latest financial report
10-Q/A - Q2 2024 - Oct 17, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % +45.1%
Debt-to-equity 634 %
Return On Equity 82.5 % -79.8%
Return On Assets 8.38 %
Operating Margin 28.7 % -32.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.1M shares -98.5%
Common Stock, Shares, Outstanding 13.6M shares -98.6%
Entity Public Float 869K USD
Common Stock, Value, Issued 13.6K USD -98.6%
Weighted Average Number of Shares Outstanding, Basic 12.8M shares
Weighted Average Number of Shares Outstanding, Diluted 12.8M shares +6546%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.58M USD -11.1%
Cost of Revenue 3.26M USD -16%
Operating Income (Loss) 2.75M USD -39.9%
Nonoperating Income (Expense) -825K USD +84.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.92M USD -115%
Net Income (Loss) Attributable to Parent 1.81M USD -116%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 14.9M USD +61.6%
Assets, Current 18.1M USD +88%
Property, Plant and Equipment, Net 27.9K USD -41.1%
Operating Lease, Right-of-Use Asset 349K USD +127%
Goodwill 5.67M USD 0%
Assets 24.7M USD +53.9%
Accounts Payable, Current 544K USD +24.3%
Liabilities, Current 13.9M USD +20.8%
Operating Lease, Liability, Noncurrent 170K USD +427%
Liabilities 14.2M USD +21.6%
Retained Earnings (Accumulated Deficit) -69.6M USD +1.34%
Stockholders' Equity Attributable to Parent 5.88M USD
Liabilities and Equity 24.7M USD +53.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities 313K USD +4.24%
Common Stock, Shares Authorized 300M shares -96%
Common Stock, Shares, Issued 13.6M shares -98.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.2M USD +683%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50K USD +3227%
Deferred Tax Assets, Valuation Allowance 5.29M USD -11.7%
Deferred Tax Assets, Gross 5.29M USD -11.7%
Depreciation 19.5K USD +105%
Lessee, Operating Lease, Liability, to be Paid 344K USD +116%
Property, Plant and Equipment, Gross 137K USD -10.3%
Operating Lease, Liability, Current 174K USD +37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 80K USD +148%
Lessee, Operating Lease, Liability, to be Paid, Year One 168K USD +32.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.61K USD
Preferred Stock, Shares Authorized 50M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.55K USD -71%
Additional Paid in Capital 19.5M USD
Depreciation, Depletion and Amortization 3.37K USD -27.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 195K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares